Skip to content

Depression and Anxiety Among Chronic Pain Patients in the Netherlands

The Prevalence of Depression and Anxiety Among Chronic Pain Patients in the Netherlands

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06545513
Enrollment
3240
Registered
2024-08-09
Start date
2022-08-30
Completion date
2024-11-19
Last updated
2025-05-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Pain, Depression, Anxiety

Keywords

Chronic pain, Depression, Anxiety

Brief summary

The aim of this study is to examine the prevalence of anxiety and depression among patients with chronic pain attending secondary and tertiary pain clinics in the Netherlands. Additionally, the study explores how pain intensity, sociodemographic factors, and the presence of anxiety or depression are associated with quality of life in this population. Using an anonymized dataset provided by the data manager, we aimed to prevent a low response rate at Amsterdam UMC and thereby reduce the risk of non-response bias.

Detailed description

Chronic pain is defined as pain which exists for a period longer than 3 months. The prevalence of chronic pain in the Netherlands is estimated to be 19 percent. Chronic pain is a complex disorder which is often challenging to treat. The dynamic interaction between de different aspects of chronic pain, like the somatic, physical and social aspects, make the treatment challenging. Patients with chronic pain have a three times increased risk of developing psychiatric symptoms (usually mood and anxiety disorders) and vice versa, patients with depression have a three times increased risk of developing chronic pain. Also independently chronic pain and depression are both invalidating disorders, regardless of age and gender. It has been found that there is an increased risk of suicide among patients with chronic pain. The complex interaction between chronic pain and depression and their cumulative effect on the quality of life in the Netherlands has not yet been completely identified. This is because the interaction between chronic pain and depression is not yet fully understood. The treatment can be improved when the interaction between pain and depression is better understood. The research acts as a preliminary investigation for the treatment of patients with chronic pain with intrvenous esketamine, a recently approved treatment for treatment resistant depression.

Interventions

None listed

Sponsors

Amsterdam UMC, location VUmc
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Patients over 18 years old with chronic pain, who have been treated at the pain clinic at Amsterdam UMC from 2020 to 2024, will be included in the study, provided they have completed the HADS questionnaires in full. Patients with incomplete HADS questionnaires and those who have filed a general objection to the use of their data for this scientific research will be excluded from participation in the analysis.

Design outcomes

Primary

MeasureTime frameDescription
Prevalence of depression2020-2024prevalence of depression among chronic pain patients

Countries

Netherlands

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026